Levocetirizine in mite-allergic children with persistent allergic rhinitis and recurrent respiratory infections

Phase 3, randomised, double-blind trial of levocetirizine in allergic rhinitis (AR), There is no canonical full disease name for "recurrent respiratory infections" because it is not recognized as a standalone disease entity in medical classification systems and asthma (3 arms), sponsored by Istituto Giannina Gaslini. Primary endpoints: Efficacy of trimestrial levocetirizine on allergic nasal symptoms vs placebo and Efficacy of monthly levocetirizine on allergic nasal symptoms vs placebo. Started Apr 2007; status: completed.